CARREGA, Paolo
 Distribuzione geografica
Continente #
EU - Europa 2.428
NA - Nord America 1.972
AS - Asia 1.233
SA - Sud America 375
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 47
Totale 6.192
Nazione #
US - Stati Uniti d'America 1.925
RU - Federazione Russa 1.230
SG - Singapore 469
CN - Cina 415
BR - Brasile 327
IT - Italia 274
IE - Irlanda 236
SE - Svezia 223
PL - Polonia 165
HK - Hong Kong 123
VN - Vietnam 93
FR - Francia 69
DE - Germania 54
GB - Regno Unito 39
UA - Ucraina 31
IN - India 29
FI - Finlandia 27
BE - Belgio 22
AR - Argentina 19
ZA - Sudafrica 17
AT - Austria 16
CA - Canada 16
ID - Indonesia 14
BD - Bangladesh 13
MX - Messico 13
TR - Turchia 11
EC - Ecuador 9
IQ - Iraq 9
MA - Marocco 9
NL - Olanda 8
UZ - Uzbekistan 8
ES - Italia 7
JP - Giappone 6
PH - Filippine 6
PK - Pakistan 6
CL - Cile 5
CO - Colombia 5
CZ - Repubblica Ceca 5
MY - Malesia 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
EG - Egitto 4
JM - Giamaica 4
PY - Paraguay 4
AL - Albania 3
AZ - Azerbaigian 3
ET - Etiopia 3
MD - Moldavia 3
RO - Romania 3
VE - Venezuela 3
AM - Armenia 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AW - Aruba 1
BG - Bulgaria 1
BO - Bolivia 1
BT - Bhutan 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GP - Guadalupe 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TW - Taiwan 1
Totale 6.057
Città #
Ashburn 354
Moscow 329
Singapore 255
Dublin 235
Chandler 188
Warsaw 165
Dallas 162
Nyköping 153
Messina 145
Beijing 127
Hong Kong 122
San Jose 95
The Dalles 83
Jacksonville 74
Ann Arbor 65
Council Bluffs 60
Los Angeles 47
Princeton 37
Lauterbourg 34
Medford 34
Ho Chi Minh City 32
Des Moines 27
Dearborn 26
Santa Clara 26
Cambridge 25
Guangzhou 23
São Paulo 22
Brussels 21
Tianjin 21
Boardman 20
Buffalo 19
New York 19
Munich 16
Redondo Beach 15
Dong Ket 14
Orem 14
Shanghai 14
Wilmington 14
Woodbridge 14
Shenyang 13
Vienna 13
Belo Horizonte 12
Nanjing 12
Hanoi 11
Jinan 11
Johannesburg 11
Rio de Janeiro 11
San Mateo 11
Stockholm 10
Zhengzhou 10
Milan 9
Seattle 9
Changsha 8
Jakarta 8
Rome 8
Tashkent 8
Brooklyn 7
Chennai 7
Genoa 7
Hebei 7
Ningbo 7
Phoenix 7
Atlanta 6
Frankfurt am Main 6
Montreal 6
São Bernardo do Campo 6
Taizhou 6
Tokyo 6
West Jordan 6
Amsterdam 5
Brno 5
Chicago 5
Da Nang 5
Genova 5
Haikou 5
London 5
Nova Iguaçu 5
Porto Alegre 5
Salvador 5
Aci Bonaccorsi 4
Baghdad 4
Boston 4
Brasília 4
Campinas 4
Canoas 4
Catania 4
Caxias do Sul 4
Columbus 4
Curitiba 4
Düsseldorf 4
Fuzhou 4
General Mamerto Natividad 4
Goiânia 4
Hangzhou 4
Houston 4
Manchester 4
Mexico City 4
Mumbai 4
Nanchang 4
North Charleston 4
Totale 3.539
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 259
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 248
NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. 217
CD56(bright) CD16(-) killer Ig-like receptor(-) NK cells display longer telomeres and acquire features of CD56(dim) NK cells upon activation 200
Cross-dressing: an alternative mechanism for antigen presentation 183
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 180
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 178
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 177
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 177
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells 171
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 168
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 167
Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence. 165
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 165
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 164
ILC in chronic inflammation, cancer and targeting with biologicals 162
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 157
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 152
The Yin and Yang of Innate Lymphoid Cells in Cancer 150
Characterisation of innate lymphoid cell subsets infiltrating colorectal carcinoma 144
Human NK cells and NK receptors. 143
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN-α Production 138
Characterization of human afferent lymph dendritic cells from seroma fluids. 138
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS) 137
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells 135
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 126
EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses 124
BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features 123
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 122
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 119
Identification of Natural Killer Cells in Tissues and Their Isolation 116
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies 110
Isolation, Expansion, and Characterization of Natural Killer Cells and Their Precursors as a Tool to Study Cancer Immunosurveillance 108
Natural Killer cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on dendritic cells 107
Microbiota and plasticity of antigen-presenting ILC3s: impact on antitumor immune response 107
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-alpha production. 94
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade 88
Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer 86
Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system database 86
Natural killer cell distribution and trafficking in human tissues. 84
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy 81
Principles of NK cell/DC crosstalk: The importance of cell dialogue for a protective immune response 79
Natural killer cells infiltrating human non small-cell lung cancer are enriched inCD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. 74
null 44
Murine models to study human NK cells in human solid tumors 39
Totale 6.192
Categoria #
all - tutte 20.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022255 0 31 3 16 13 8 29 17 5 16 34 83
2022/2023728 67 68 39 61 49 72 8 52 273 2 15 22
2023/2024173 13 28 29 12 14 23 1 9 6 4 4 30
2024/2025913 23 4 14 51 39 29 25 233 183 62 102 148
2025/20263.106 179 180 186 207 278 580 374 427 413 165 61 56
2026/2027135 60 75 0 0 0 0 0 0 0 0 0 0
Totale 6.192